Valuation: Boule Diagnostics AB

Market Cap 138M 14.45M 12.57M 11.7M 10.74M 20.28M 1.38B 20.59M 54.1M 687M 54.28M 53.09M 2.3B P/E 2026 *
-14.1x
P/E 2027 * 16x
Enterprise Value 334M 35.06M 30.48M 28.37M 26.05M 49.19M 3.35B 49.95M 131M 1.67B 132M 129M 5.59B EV / Sales 2026 *
0.74x
EV / Sales 2027 * 0.67x
Free-Float
53.64%
Yield 2026 *
-
Yield 2027 * -
1 day+7.61%
1 week+4.66%
Current month+2.96%
1 month+1.60%
3 months+7.30%
6 months-29.26%
Current year-22.20%
1 week 3.41
Extreme 3.41
3.95
1 month 2.75
Extreme 2.75
3.99
Current year 2.75
Extreme 2.75
5.68
1 year 2.75
Extreme 2.75
6.64
3 years 2.75
Extreme 2.75
12.62
5 years 2.75
Extreme 2.75
61.2
10 years 2.75
Extreme 2.75
108.88
Manager TitleAgeSince
Chief Executive Officer - 22/06/2026
Director of Finance/CFO 54 11/02/2026
Chief Tech/Sci/R&D Officer - 01/01/2019
Director TitleAgeSince
Director/Board Member 59 01/01/2014
Chairman 73 01/01/2021
Chairman 74 01/01/2023
Date Insider Type Main position Quantity % Market Cap.
2/27/23 A Buy

Chief Financial Officer

8,000 0.0206%
2/6/23 A Buy

Director

7,083 0.0182%
2/17/22 A Buy

Director

2,000 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
+7.61%+4.66%-41.77%-61.57% 14.44M
-0.59%+0.76%+22.42%+4.36% 214B
+0.10%+2.36%-0.58%-23.15% 138B
+0.31%+4.98%-26.35%+9.22% 125B
+0.18%+3.97%-56.15%-11.27% 68.37B
-0.81%+4.40%+8.77%+5.11% 50.05B
-0.91%+5.13%-22.07%-30.22% 47.67B
-0.14%-0.27%+20.36%+13.48% 39.18B
-0.67%+0.69%+30.65%+36.58% 37.34B
-2.81%+12.17%-4.72%-12.88% 31.59B
Average +0.26%+7.20%-6.94%-7.03% 75.12B
Weighted average by Cap. -0.31%+7.51%-1.62%-2.10%

Financials

2026 *2027 *
Net sales 453M 47.51M 41.3M 38.44M 35.29M 66.65M 4.54B 67.68M 178M 2.26B 178M 175M 7.57B 483M 50.68M 44.05M 41M 37.65M 71.09M 4.84B 72.19M 190M 2.41B 190M 186M 8.08B
Net income -9.77M -1.02M -891K -829K -761K -1.44M -97.82M -1.46M -3.84M -48.7M -3.85M -3.76M -163M 8.6M 901K 784K 729K 670K 1.26M 86.04M 1.28M 3.37M 42.83M 3.38M 3.31M 144M
Net Debt 197M 20.61M 17.91M 16.67M 15.31M 28.91M 1.97B 29.36M 77.14M 979M 77.39M 75.69M 3.28B 185M 19.35M 16.82M 15.65M 14.37M 27.14M 1.85B 27.56M 72.42M 919M 72.66M 71.06M 3.08B
Logo Boule Diagnostics AB
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Employees
200
Date Price Change Volume
31/07/26 SEK 3.820 +7.61% 14,298
30/07/26 SEK 3.550 -2.47% 59,753
29/07/26 SEK 3.640 +4.00% 19,498
28/07/26 SEK 3.500 -7.41% 16,900
27/07/26 SEK 3.780 +3.56% 1,991
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3.550SEK
Average target price
3.800SEK
Spread / Average Target
+7.04%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BOUL Stock